Grove Collaborative Holdings, Inc. (GROV)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $44.69M
Last updated: Nov 17, 2026 at 11:00 AM ET
Grove Collaborative Holdings, Inc. (GROV) Earnings: Report Dates and Results
Grove Collaborative Holdings (GROV) is expected to report earnings on Mar 3, 2027. In the quarter ended Sep 30, 2026, Grove Collaborative Holdings reported EPS of -$0.01, above the -$0.05 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
GROV has an expected report date of Mar 3, 2027.
GROV Earnings Call
The latest GROV earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 16 quarters below that had an estimate, GROV beat 7 and missed 9. Revenue for the quarter ended Sep 30, 2026 was $36.82M, down 15.8% from $43.73M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.01 | -$0.05 | -$0.05 - -$0.05 | +80.00% | Beat | N/A | 1 | 0 up, 1 down | Nov 10, 2026 | $36.82M |
| Jun 30, 2026 | -$0.03 | -$0.06 | -$0.06 - -$0.06 | +50.00% | Beat | N/A | 1 | 0 up, 1 down | Aug 6, 2026 | $36.57M |
| Mar 31, 2026 | -$0.04 | -$0.09 | -$0.09 - -$0.09 | +55.56% | Beat | N/A | 1 | 0 up, 1 down | May 7, 2026 | $36.22M |
| Dec 31, 2025 | -$0.05 | -$0.09 | -$0.09 - -$0.09 | +44.44% | Beat | N/A | 1 | 1 up, 0 down | Mar 5, 2026 | $42.41M |
| Sep 30, 2025 | -$0.08 | -$0.14 | -$0.14 - -$0.14 | +42.86% | Beat | N/A | 1 | 1 up, 0 down | Nov 13, 2025 | $43.73M |
| Jun 30, 2025 | -$0.10 | -$0.13 | N/A | +23.08% | Beat | N/A | 1 | 0 up, 1 down | Aug 7, 2025 | $44.03M |
| Mar 31, 2025 | -$0.05 | -$0.03 | N/A | -66.67% | Miss | N/A | 1 | 1 up, 0 down | May 14, 2025 | $43.55M |
| Dec 31, 2024 | -$0.34 | -$0.15 | N/A | -129.73% | Miss | N/A | 1 | 0 up, 0 down | Mar 11, 2025 | $49.50M |
| Sep 30, 2024 | -$0.22 | -$0.15 | N/A | -46.67% | Miss | N/A | 1 | 0 up, 0 down | Nov 12, 2024 | $48.28M |
| Jun 30, 2024 | -$0.22 | -$0.15 | -$0.15 - -$0.15 | -46.67% | Miss | N/A | 1 | 0 up, 1 down | Aug 8, 2024 | $52.10M |
| Mar 31, 2024 | -$0.18 | -$0.16 | -$0.16 - -$0.16 | -12.50% | Miss | N/A | 1 | 0 up, 0 down | May 14, 2024 | $53.55M |
| Dec 31, 2023 | -$0.27 | -$0.23 | -$0.23 - -$0.23 | -17.39% | Miss | N/A | 1 | 0 up, 0 down | Mar 6, 2024 | $59.86M |
| Sep 30, 2023 | -$0.21 | -$0.15 | -$0.15 - -$0.15 | -40.00% | Miss | -520.0% | 1 | 0 up, 0 down | Nov 9, 2023 | $61.75M |
| Jun 30, 2023 | -$0.35 | -$0.31 | -$0.31 - -$0.31 | -12.90% | Miss | N/A | 1 | 0 up, 0 down | Aug 14, 2023 | $66.11M |
| Mar 31, 2023 | -$0.49 | -$0.40 | -$0.40 - -$0.40 | -22.50% | Miss | N/A | 1 | 0 up, 0 down | May 11, 2023 | $71.56M |
| Dec 31, 2022 | -$0.05 | -$0.09 | -$0.09 - -$0.09 | +44.44% | Beat | N/A | 1 | 0 up, 0 down | Mar 14, 2023 | $74.04M |
| Sep 30, 2022 | $0.05 | N/A | N/A | N/A | N/A | -54.5% | N/A | N/A | Nov 10, 2022 | $77.73M |
| Jun 30, 2022 | -$1.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 11, 2022 | $79.28M |
| Mar 31, 2022 | -$0.47 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 2, 2022 | $90.48M |
| Dec 31, 2021 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 22, 2022 | $189.48M |
| Sep 30, 2021 | $0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2021 | $95.18M |
| Jun 30, 2021 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 10, 2021 | $99.02M |
| Mar 31, 2021 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2021 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.28, after -$0.96 the year before. It was $0.05 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.28 | N/A |
| Dec 31, 2024 | -$0.96 | N/A |
| Dec 31, 2023 | -$1.32 | N/A |
| Dec 31, 2022 | -$1.53 | -3160.0% |
| Dec 31, 2021 | $0.05 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 3,900 words across 4 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 3,863 | 4 | |
| 2026Q2 | Jun 30, 2026 | 2,985 | 3 | |
| 2026Q1 | Mar 31, 2026 | 3,805 | 4 | |
| 2025Q4 | Dec 31, 2025 | 3,730 | 4 | |
| 2025Q3 | Sep 30, 2025 | 3,628 | 4 | |
| 2025Q2 | Jun 30, 2025 | 4,007 | 4 | |
| 2025Q1 | Mar 31, 2025 | 3,444 | 4 | |
| 2024Q4 | Dec 31, 2024 | 3,818 | 4 |
2026Q3 Earnings Call
Opening remarks
Jeff Yurcisin CEO Thank you, operator, and thank you all for joining us. Inside Grove, we have started calling this moment a new Day 1. After years of transforming and stabilizing the business, we are entering a new chapter, and the results are starting to show it. Revenue grew sequentially for the second straight quarter, and we have delivered positive GAAP net income alongside positive adjusted EBITDA, the first time we have done both in the same quarter as a public company. Today, I want to focus on where growth is headed. That starts with human and environmental health. This new Day 1 is about doubling down on human health. We believe 57 million consumers want a trusted guide to healthier products, and Grove is uniquely positioned to be that guide, with ingredient standards we believe are among the highest in our industry, a curated assortment, and years of customer trust. Planetary health will always be a part of who we are, but our focus is helping customers build healthier homes for the people they love. In September, we published the Grove Standard, developed with guidance from our Independent Science Council. Every product we sell is screened against thousands of restricted chemicals, including PFAS, phthalates, and bisphenols. We do the hard work on ingredients so our customers do not have to. And the standard is not static. Our Science Council reviews it as the research evolves. Our customers want more than a list of what has been left out. They want to know what is actually good for their family. Parents are reading labels on everything from dish soap to snacks, and concerns about chemicals like PFAS are now mainstream, not niche. That is why we are expanding from a clean home to the health of the whole household, with the same standards and the same trust. Over the coming quarters, we plan to make it easier for customers to see why each product earns its place on the Grove platform and to swap within their home for healthier options. Building on product pages, we relaunched the quarter to educate, not just sell. That trust is our advantage. In a Grove survey this year, 94% of more than 1,000 Grove customers said they trust Grove more than Amazon to sell products that are safe for their families. And it shows up in how they shop. Customers who buy wellness products from Grove have had 33% higher average order values and purchased twice as often, based on an internal analysis of Grove customer orders in 2025. We are not trying to be everything to everyone.
Frequently Asked Questions About GROV
When is Grove Collaborative Holdings's next earnings date?
Grove Collaborative Holdings's next earnings report is expected for Mar 3, 2027.
Did GROV beat earnings estimates last quarter?
Yes. Grove Collaborative Holdings reported EPS of -$0.01 for the quarter ended Sep 30, 2026, above the -$0.05 estimate, a 80.00% surprise.
What EPS do analysts expect from GROV next quarter?
The consensus EPS estimate for Grove Collaborative Holdings for the quarter ending Dec 31, 2026 is -$0.04 from 3 analysts, with estimates from -$0.04 to -$0.04.
How often does GROV beat earnings estimates?
Grove Collaborative Holdings beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +12.44%.
GROV pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors